Market Cap

Orion Oyj Market Capitalization:

€5.84 Billion

EUR as of July 1, 2024

US$6.27 Billion

business Orion Oyj Company Profile

Orion Oyj Main Stock Listings

Market Capitalization History of Orion Oyj

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $808.65 B
Johnson & Johnson $350.63 B
Merck $318.75 B
AbbVie $295.34 B
AstraZeneca $236.45 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Orion Oyj market cap

Date Market Cap YoY Change
Jan. 1, 2024 €5.59 B -24.21%
Jan. 1, 2023 €7.37 B 47.84%
Jan. 1, 2022 €4.99 B -6.03%
Jan. 1, 2021 €5.31 B -10.02%
Jan. 1, 2020 €5.90 B 37.66%
Jan. 1, 2019 €4.28 B -10.98%
Jan. 1, 2018 €4.81 B -19.31%
Jan. 1, 2017 €5.96 B 44.33%
Jan. 1, 2016 €4.13 B 1.99%
Jan. 1, 2015 €4.05 B 50.46%
Jan. 1, 2014 €2.69 B -4.91%
Jan. 1, 2013 €2.83 B 35.19%
Jan. 1, 2012 €2.09 B -8.84%
Jan. 1, 2011 €2.30 B 4.49%
Jan. 1, 2010 €2.20 B 16.25%
Jan. 1, 2009 €1.89 B -9.33%
Jan. 1, 2008 €2.09 B -14.04%
Jan. 1, 2007 €2.43 B 4.18%
Jan. 1, 2006 €2.33 B 35.63%
Jan. 1, 2005 €1.72 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Orion Oyj Categories

Finland languages Healthcare languages Drug Manufacturers—General
Finland Healthcare Finland Drug Manufacturers—General

Stocks & Indices

Orion Oyj has the following listings and related stock indices.


Stock: OMXH: ORNAV

Stock: OMXH: ORNBV

Stock: FSX: OFK

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.